SCHEMBL735361

SCHEMBL735361

CCCCCCCCCCCCc1cc2c(cc1CCCCCCCCCCCC)C(=O)c1cc(I)c(Br)cc1C2=O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ELANE P08246 4/20 0.36
CTSG P08311 2/20 0.36
NR1H2 P55055 1/20 0.35
NR1H3 Q13133 1/20 0.35
ALOX5 P09917 4/20 0.34
MEN1 O00255 1/20 0.34
TP53 P04637 1/20 0.34
CYP3A4 P08684 1/20 0.34
MAPT P10636 1/20 0.34
TYR P14679 1/20 0.34
ALOX15 P16050 1/20 0.34
TSHR P16473 1/20 0.34
HTT P42858 1/20 0.34
KMT2A Q03164 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
PTPN1 P18031 1/20 0.34
GPR84 Q9NQS5 7/20 0.33
HCAR2 Q8TDS4 1/20 0.33
SIRT2 Q8IXJ6 1/20 0.32
MPEG1 Q2M385 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12403125 0.77 ALOX5 (0.42) NR1H2NR1H3ALOX5MEN1TP53
SCHEMBL733803 0.76 ALOX5 (0.37) ALOX5MEN1TP53CYP3A4MAPT
SCHEMBL543220 0.75 ELANE (0.42) ELANECTSGNR1H2NR1H3ALOX5
SCHEMBL23958837 0.74 S100A4 (0.36)
SCHEMBL12925073 0.72 ALOX5 (0.47) ALOX5MEN1TP53CYP3A4MAPT
SCHEMBL725139 0.72 ALOX5 (0.47) ALOX5MEN1TP53CYP3A4MAPT
SCHEMBL28453738 0.72 ALOX5 (0.47) ALOX5MEN1TP53CYP3A4MAPT
SCHEMBL28460292 0.72 ALOX5 (0.47) ALOX5MEN1TP53CYP3A4MAPT
SCHEMBL17767410 0.70 ALOX5 (0.43) ALOX5MEN1TP53CYP3A4MAPT
SCHEMBL30494516 0.70 S100A4 (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2067782-B2 HETEROACENE DERIVATIVE, TETRAHALOTERPHENYL DERIVATIVE, AND THEIR PRODUCTION METHODS TOSOH CORP (JP) 2018-06-27 EP disclosed
EP-2067782-B1 HETEROACENE DERIVATIVE, TETRAHALOTERPHENYL DERIVATIVE, AND THEIR PRODUCTION METHODS TOSOH CORP (JP) 2014-08-13 EP disclosed
US-8138355-B2 Heteroacene derivative, tetrahaloterphenyl derivative, and processes for producing the same TOSOH CORPORATION (JP) 2012-03-20 US disclosed
US-20090261300-A1 HETEROACENE DERIVATIVE, TETRAHALOTERPHENYL DERIVATIVE, AND PROCESSES FOR PRODUCING THE SAME TOSOH CORPORATION (JP) 2009-10-22 US disclosed
EP-2067782-A1 HETEROACENE DERIVATIVE, TETRAHALOTERPHENYL DERIVATIVE, AND THEIR PRODUCTION METHODS Tosoh Corporation (JP) 2009-06-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090261300-A1 HETEROACENE DERIVATIVE, TETRAHALOTERPHENYL DERIVATIVE, AND PROCESSES FOR PRODUCING THE SAME AS3MT, TERT, TEAD1 ELANE 1298/4885CTSG 4580/4885NR1H2 2275/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.